Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials
Related Posts
Shammas R, Gudino-Rosales S, Kneiber D, Sarantopoulos GP, Aung T. Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma[...]
Brinks AL, Lawrence CN, Kearney CA, Maas D, Gillespie C, Adotama P, Senna M, Bordone L, Hordinsky M, Farah R, Aguh C, Mesinkovska N, Colavincenzo[...]
Humm E, Wofford NQ, Sieber JR, Morselli M, Pellegrini M, McInerney MJ, Ha SM, Gunsalus RP. Whole genome sequence of the syntrophic fatty acid-degrading bacterium Syntrophomonas[...]